Medinova Diagnostic Services Ltd is a trusted healthcare company specializing in diagnostic and pathology services. Established to provide accurate and timely medical testing, the company offers a wide range of services, including blood tests, imaging, and health check-ups. Medinova Diagno Share Price on BOM as of 10 December 2024 is 40.20 INR. Here are more details on Medinova Diagno Share Price Target 2024, 2025, 2026 to 2030.
Medinova Diagnostic Services Ltd: Market Overview
- Open Price: ₹41.90
- High Price: ₹41.90
- Low Price: ₹39.60
- Previous Close: ₹41.02
- Volume: 1,187
- Value (Lacs): ₹0.48
- VWAP: ₹40.39
- UC Limit: ₹49.22
- LC Limit: ₹32.82
- P/E ratio: 20.94
- Div yield: N/A
- 52-wk high: ₹64.50
- 52-wk low: ₹30.66
- Mkt cap: ₹40.13Cr
- Face Value: ₹10
Medinova Diagno Share Price Chart
Medinova Diagno Share Price Target Tomorrow 2024 To 2030
| Medinova Diagno Share Price Target Years | Share Price Target |
| 2024 | ₹65 |
| 2025 | ₹75 |
| 2026 | ₹85 |
| 2027 | ₹95 |
| 2028 | ₹105 |
| 2029 | ₹115 |
| 2030 | ₹125 |
Medinova Diagno Share Price Target 2024
Medinova Diagno share price target 2024 Expected target could be ₹65. Here are four key factors that could influence the growth of Medinova Diagnostic Services’ share price target for 2024:
- Increasing Demand for Healthcare Services: With rising health awareness and demand for preventive care, more people are opting for diagnostic tests. This trend can drive revenue growth for Medinova, positively impacting its share price.
- Technology Integration: Adoption of advanced diagnostic technologies, such as AI-driven imaging or automated lab processes, can improve service accuracy and efficiency, enhancing the company’s competitive edge.
- Geographical Expansion: Expanding its network of diagnostic centers to underserved areas can increase market reach and customer base, contributing to higher growth and valuation.
-
Government Healthcare Initiatives: Supportive policies promoting affordable healthcare and diagnostic services could create growth opportunities, boosting the company’s performance and share price potential.
Medinova Diagno Share Price Target 2025
Medinova Diagno share price target 2025 Expected target could be ₹75. Here are four key factors that could influence the growth of Medinova Diagnostic Services’ share price target for 2025:
- Rising Health Awareness: Increasing awareness about regular health check-ups and early disease detection is likely to drive higher demand for diagnostic services, boosting Medinova’s growth.
- Expansion of Services: Introducing specialized diagnostic tests, such as genetic testing or advanced imaging, can cater to a broader customer base and generate additional revenue streams.
- Strategic Partnerships: Collaborating with hospitals, clinics, or corporate wellness programs can strengthen Medinova’s market position and create new growth opportunities.
-
Economic Growth and Urbanization: As urban areas expand and disposable incomes rise, more people are expected to access private healthcare services, contributing to Medinova’s revenue growth and market valuation.
Medinova Diagno Share Price Target 2030
Medinova Diagno share price target 2030 Expected target could be ₹125. Here are four key risks and challenges that could impact Medinova Diagnostic Services’ share price target for 2030:
- Intense Competition: The diagnostic industry is highly competitive, with both established players and new entrants offering similar services. This could pressure Medinova’s market share and pricing strategy.
- Technological Advancements: Rapid advancements in diagnostic technologies may require continuous investment. Falling behind in adopting new technologies could affect the company’s relevance and competitiveness.
- Regulatory Changes: Stricter healthcare regulations or licensing requirements could increase operational complexities and costs, potentially affecting profitability.
-
Economic Slowdowns: During economic downturns, customers may delay or reduce spending on preventive healthcare, impacting the demand for diagnostic services and the company’s financial performance.
Shareholding Pattern For Medinova Diagnostic Services Ltd
- Promoters: 62.14%
- Public: 37.86%
Medinova Diagnostic Services Ltd Financials
| (INR) | 2024 | Y/Y change |
| Revenue | 101.65M | 1.72% |
| Operating expense | 33.21M | -0.90% |
| Net income | 19.99M | 20.04% |
| Net profit margin | 19.66 | 18.01% |
| Earnings per share | — | — |
| EBITDA | 27.63M | 6.37% |
| Effective tax rate | 12.29% | — |
Read Also:- Stock Market Update – Dreamfolks Services Share Price Target Tomorrow 2024 To 2030
